0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Personalized Therapy Biosimulation Platform Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25P14490
Home | Market Reports | Health| Health Conditions
Global Personalized Therapy Biosimulation Platform Market Research Report 2023
BUY CHAPTERS

Global Personalized Therapy Biosimulation Platform Market Research Report 2025

Code: QYRE-Auto-25P14490
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Personalized Therapy Biosimulation Platform Market Size

The global market for Personalized Therapy Biosimulation Platform was valued at US$ 1808 million in the year 2024 and is projected to reach a revised size of US$ 4633 million by 2031, growing at a CAGR of 14.6% during the forecast period.

Personalized Therapy Biosimulation Platform Market

Personalized Therapy Biosimulation Platform Market

Personalized Therapy Biosimulation refers to biosimulating a patient"s unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient"s Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.
Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Therapy Biosimulation Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Therapy Biosimulation Platform.
The Personalized Therapy Biosimulation Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Therapy Biosimulation Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Therapy Biosimulation Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Personalized Therapy Biosimulation Platform Market Report

Report Metric Details
Report Name Personalized Therapy Biosimulation Platform Market
Accounted market size in year US$ 1808 million
Forecasted market size in 2031 US$ 4633 million
CAGR 14.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic, Shanghai Lide
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Personalized Therapy Biosimulation Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Personalized Therapy Biosimulation Platform Market growing?

Ans: The Personalized Therapy Biosimulation Platform Market witnessing a CAGR of 14.6% during the forecast period 2025-2031.

What is the Personalized Therapy Biosimulation Platform Market size in 2031?

Ans: The Personalized Therapy Biosimulation Platform Market size in 2031 will be US$ 4633 million.

Who are the main players in the Personalized Therapy Biosimulation Platform Market report?

Ans: The main players in the Personalized Therapy Biosimulation Platform Market are Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic, Shanghai Lide

What are the Application segmentation covered in the Personalized Therapy Biosimulation Platform Market report?

Ans: The Applications covered in the Personalized Therapy Biosimulation Platform Market report are Pharmaceutical and Biotech Companies, Research Institutions, Hospital, Others

What are the Type segmentation covered in the Personalized Therapy Biosimulation Platform Market report?

Ans: The Types covered in the Personalized Therapy Biosimulation Platform Market report are Pharmacokinetic, Pharmacoeconomics

Recommended Reports

Cancer Therapy Markets

Advanced Therapy Devices

Personalized & Biologic Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmacokinetic
1.2.3 Pharmacoeconomics
1.3 Market by Application
1.3.1 Global Personalized Therapy Biosimulation Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotech Companies
1.3.3 Research Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Therapy Biosimulation Platform Market Perspective (2020-2031)
2.2 Global Personalized Therapy Biosimulation Platform Growth Trends by Region
2.2.1 Global Personalized Therapy Biosimulation Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Therapy Biosimulation Platform Historic Market Size by Region (2020-2025)
2.2.3 Personalized Therapy Biosimulation Platform Forecasted Market Size by Region (2026-2031)
2.3 Personalized Therapy Biosimulation Platform Market Dynamics
2.3.1 Personalized Therapy Biosimulation Platform Industry Trends
2.3.2 Personalized Therapy Biosimulation Platform Market Drivers
2.3.3 Personalized Therapy Biosimulation Platform Market Challenges
2.3.4 Personalized Therapy Biosimulation Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Therapy Biosimulation Platform Players by Revenue
3.1.1 Global Top Personalized Therapy Biosimulation Platform Players by Revenue (2020-2025)
3.1.2 Global Personalized Therapy Biosimulation Platform Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Therapy Biosimulation Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Therapy Biosimulation Platform Revenue
3.4 Global Personalized Therapy Biosimulation Platform Market Concentration Ratio
3.4.1 Global Personalized Therapy Biosimulation Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Therapy Biosimulation Platform Revenue in 2024
3.5 Global Key Players of Personalized Therapy Biosimulation Platform Head office and Area Served
3.6 Global Key Players of Personalized Therapy Biosimulation Platform, Product and Application
3.7 Global Key Players of Personalized Therapy Biosimulation Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Therapy Biosimulation Platform Breakdown Data by Type
4.1 Global Personalized Therapy Biosimulation Platform Historic Market Size by Type (2020-2025)
4.2 Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Type (2026-2031)
5 Personalized Therapy Biosimulation Platform Breakdown Data by Application
5.1 Global Personalized Therapy Biosimulation Platform Historic Market Size by Application (2020-2025)
5.2 Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Therapy Biosimulation Platform Market Size (2020-2031)
6.2 North America Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025)
6.4 North America Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Therapy Biosimulation Platform Market Size (2020-2031)
7.2 Europe Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025)
7.4 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size (2020-2031)
8.2 Asia-Pacific Personalized Therapy Biosimulation Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Therapy Biosimulation Platform Market Size (2020-2031)
9.2 Latin America Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025)
9.4 Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size (2020-2031)
10.2 Middle East & Africa Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellworks Group
11.1.1 Cellworks Group Company Details
11.1.2 Cellworks Group Business Overview
11.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Introduction
11.1.4 Cellworks Group Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.1.5 Cellworks Group Recent Development
11.2 Certara
11.2.1 Certara Company Details
11.2.2 Certara Business Overview
11.2.3 Certara Personalized Therapy Biosimulation Platform Introduction
11.2.4 Certara Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.2.5 Certara Recent Development
11.3 Simulation Plus
11.3.1 Simulation Plus Company Details
11.3.2 Simulation Plus Business Overview
11.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Introduction
11.3.4 Simulation Plus Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.3.5 Simulation Plus Recent Development
11.4 Schrodinger
11.4.1 Schrodinger Company Details
11.4.2 Schrodinger Business Overview
11.4.3 Schrodinger Personalized Therapy Biosimulation Platform Introduction
11.4.4 Schrodinger Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.4.5 Schrodinger Recent Development
11.5 In Silico Biosciences
11.5.1 In Silico Biosciences Company Details
11.5.2 In Silico Biosciences Business Overview
11.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Introduction
11.5.4 In Silico Biosciences Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.5.5 In Silico Biosciences Recent Development
11.6 Genedata
11.6.1 Genedata Company Details
11.6.2 Genedata Business Overview
11.6.3 Genedata Personalized Therapy Biosimulation Platform Introduction
11.6.4 Genedata Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.6.5 Genedata Recent Development
11.7 Physiomics
11.7.1 Physiomics Company Details
11.7.2 Physiomics Business Overview
11.7.3 Physiomics Personalized Therapy Biosimulation Platform Introduction
11.7.4 Physiomics Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.7.5 Physiomics Recent Development
11.8 Insilico Biotechology
11.8.1 Insilico Biotechology Company Details
11.8.2 Insilico Biotechology Business Overview
11.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Introduction
11.8.4 Insilico Biotechology Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.8.5 Insilico Biotechology Recent Development
11.9 Chemical Computing Group ULC(CCG)
11.9.1 Chemical Computing Group ULC(CCG) Company Details
11.9.2 Chemical Computing Group ULC(CCG) Business Overview
11.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Introduction
11.9.4 Chemical Computing Group ULC(CCG) Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.9.5 Chemical Computing Group ULC(CCG) Recent Development
11.10 Evidera
11.10.1 Evidera Company Details
11.10.2 Evidera Business Overview
11.10.3 Evidera Personalized Therapy Biosimulation Platform Introduction
11.10.4 Evidera Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.10.5 Evidera Recent Development
11.11 AnyLogic
11.11.1 AnyLogic Company Details
11.11.2 AnyLogic Business Overview
11.11.3 AnyLogic Personalized Therapy Biosimulation Platform Introduction
11.11.4 AnyLogic Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.11.5 AnyLogic Recent Development
11.12 Shanghai Lide
11.12.1 Shanghai Lide Company Details
11.12.2 Shanghai Lide Business Overview
11.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Introduction
11.12.4 Shanghai Lide Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025)
11.12.5 Shanghai Lide Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pharmacokinetic
 Table 3. Key Players of Pharmacoeconomics
 Table 4. Global Personalized Therapy Biosimulation Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Personalized Therapy Biosimulation Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Personalized Therapy Biosimulation Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Personalized Therapy Biosimulation Platform Market Share by Region (2020-2025)
 Table 8. Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Personalized Therapy Biosimulation Platform Market Share by Region (2026-2031)
 Table 10. Personalized Therapy Biosimulation Platform Market Trends
 Table 11. Personalized Therapy Biosimulation Platform Market Drivers
 Table 12. Personalized Therapy Biosimulation Platform Market Challenges
 Table 13. Personalized Therapy Biosimulation Platform Market Restraints
 Table 14. Global Personalized Therapy Biosimulation Platform Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Personalized Therapy Biosimulation Platform Market Share by Players (2020-2025)
 Table 16. Global Top Personalized Therapy Biosimulation Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Therapy Biosimulation Platform as of 2024)
 Table 17. Ranking of Global Top Personalized Therapy Biosimulation Platform Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Personalized Therapy Biosimulation Platform Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Personalized Therapy Biosimulation Platform, Headquarters and Area Served
 Table 20. Global Key Players of Personalized Therapy Biosimulation Platform, Product and Application
 Table 21. Global Key Players of Personalized Therapy Biosimulation Platform, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Personalized Therapy Biosimulation Platform Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2020-2025)
 Table 25. Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2026-2031)
 Table 27. Global Personalized Therapy Biosimulation Platform Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2020-2025)
 Table 29. Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2026-2031)
 Table 31. North America Personalized Therapy Biosimulation Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Personalized Therapy Biosimulation Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Personalized Therapy Biosimulation Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Personalized Therapy Biosimulation Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Personalized Therapy Biosimulation Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Cellworks Group Company Details
 Table 47. Cellworks Group Business Overview
 Table 48. Cellworks Group Personalized Therapy Biosimulation Platform Product
 Table 49. Cellworks Group Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 50. Cellworks Group Recent Development
 Table 51. Certara Company Details
 Table 52. Certara Business Overview
 Table 53. Certara Personalized Therapy Biosimulation Platform Product
 Table 54. Certara Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 55. Certara Recent Development
 Table 56. Simulation Plus Company Details
 Table 57. Simulation Plus Business Overview
 Table 58. Simulation Plus Personalized Therapy Biosimulation Platform Product
 Table 59. Simulation Plus Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 60. Simulation Plus Recent Development
 Table 61. Schrodinger Company Details
 Table 62. Schrodinger Business Overview
 Table 63. Schrodinger Personalized Therapy Biosimulation Platform Product
 Table 64. Schrodinger Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 65. Schrodinger Recent Development
 Table 66. In Silico Biosciences Company Details
 Table 67. In Silico Biosciences Business Overview
 Table 68. In Silico Biosciences Personalized Therapy Biosimulation Platform Product
 Table 69. In Silico Biosciences Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 70. In Silico Biosciences Recent Development
 Table 71. Genedata Company Details
 Table 72. Genedata Business Overview
 Table 73. Genedata Personalized Therapy Biosimulation Platform Product
 Table 74. Genedata Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 75. Genedata Recent Development
 Table 76. Physiomics Company Details
 Table 77. Physiomics Business Overview
 Table 78. Physiomics Personalized Therapy Biosimulation Platform Product
 Table 79. Physiomics Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 80. Physiomics Recent Development
 Table 81. Insilico Biotechology Company Details
 Table 82. Insilico Biotechology Business Overview
 Table 83. Insilico Biotechology Personalized Therapy Biosimulation Platform Product
 Table 84. Insilico Biotechology Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 85. Insilico Biotechology Recent Development
 Table 86. Chemical Computing Group ULC(CCG) Company Details
 Table 87. Chemical Computing Group ULC(CCG) Business Overview
 Table 88. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product
 Table 89. Chemical Computing Group ULC(CCG) Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 90. Chemical Computing Group ULC(CCG) Recent Development
 Table 91. Evidera Company Details
 Table 92. Evidera Business Overview
 Table 93. Evidera Personalized Therapy Biosimulation Platform Product
 Table 94. Evidera Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 95. Evidera Recent Development
 Table 96. AnyLogic Company Details
 Table 97. AnyLogic Business Overview
 Table 98. AnyLogic Personalized Therapy Biosimulation Platform Product
 Table 99. AnyLogic Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 100. AnyLogic Recent Development
 Table 101. Shanghai Lide Company Details
 Table 102. Shanghai Lide Business Overview
 Table 103. Shanghai Lide Personalized Therapy Biosimulation Platform Product
 Table 104. Shanghai Lide Revenue in Personalized Therapy Biosimulation Platform Business (2020-2025) & (US$ Million)
 Table 105. Shanghai Lide Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Personalized Therapy Biosimulation Platform Picture
 Figure 2. Global Personalized Therapy Biosimulation Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Personalized Therapy Biosimulation Platform Market Share by Type: 2024 VS 2031
 Figure 4. Pharmacokinetic Features
 Figure 5. Pharmacoeconomics Features
 Figure 6. Global Personalized Therapy Biosimulation Platform Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Personalized Therapy Biosimulation Platform Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical and Biotech Companies Case Studies
 Figure 9. Research Institutions Case Studies
 Figure 10. Hospital Case Studies
 Figure 11. Others Case Studies
 Figure 12. Personalized Therapy Biosimulation Platform Report Years Considered
 Figure 13. Global Personalized Therapy Biosimulation Platform Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Personalized Therapy Biosimulation Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Personalized Therapy Biosimulation Platform Market Share by Region: 2024 VS 2031
 Figure 16. Global Personalized Therapy Biosimulation Platform Market Share by Players in 2024
 Figure 17. Global Top Personalized Therapy Biosimulation Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Therapy Biosimulation Platform as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Personalized Therapy Biosimulation Platform Revenue in 2024
 Figure 19. North America Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Personalized Therapy Biosimulation Platform Market Share by Country (2020-2031)
 Figure 21. United States Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Personalized Therapy Biosimulation Platform Market Share by Country (2020-2031)
 Figure 25. Germany Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Personalized Therapy Biosimulation Platform Market Share by Region (2020-2031)
 Figure 33. China Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Personalized Therapy Biosimulation Platform Market Share by Country (2020-2031)
 Figure 41. Mexico Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Personalized Therapy Biosimulation Platform Market Share by Country (2020-2031)
 Figure 45. Turkey Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Personalized Therapy Biosimulation Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Cellworks Group Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 49. Certara Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 50. Simulation Plus Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 51. Schrodinger Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 52. In Silico Biosciences Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 53. Genedata Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 54. Physiomics Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 55. Insilico Biotechology Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 56. Chemical Computing Group ULC(CCG) Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 57. Evidera Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 58. AnyLogic Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 59. Shanghai Lide Revenue Growth Rate in Personalized Therapy Biosimulation Platform Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart